References
- Denham J W. The radiation dose-response relationship for control of primary breast cancer. Radiother Oncol 1986; 7: 107–23
- Cuzick J, Stewart H, Peto R, et al. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep 1987; 71: 15–29
- Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Treatment of early breast cancer. Worldwide evidence 1985–1990. Oxford University Press, Oxford 1990
- Fornander T, Rutqvist L E, Cedermark B, et al. Adjuvant tamoxifen in early breast cancer: Occurence of new primary cancers. Lancet 1989; 1: 117–20
- Rydén S, Möller T, Hafström L O, et al. Adjuvant therapy of breast cancer: Compliance and data validity in a multicenter trial. Controlled Clin Trials 1986; 7: 290–305
- Rydén S, Aspegren K, Borgström S, et al. Adjuvant therapy for postmenopausal patients with stage II breast cancer. Stockholm 1985; 157, ECCO 3, Abstract book
- Rydén S, Fernö M, Borg Å, Hafström L O, Möller T, Norgren A. Prognostic significance of estrogen and progesterone receptors in stage II breast cancer. J Surg Oncol 1988; 37: 221–6
- Arwidi Å, Aspegren K, Augustsson N E, Hafström L O, Norgren A, Svahn-Tapper G. Postoperative radiation therapy in mammary carcinoma stage II. Target volume, organs at risk, absorbed dose, time-dose schedule, and dose to organs at risk in a prospective investigation. Acta Radiol Oncol 1979; 18: 273–81
- Möller T R. The role of a regional tumour registry in oncologic research. Computers in radiotherapy and oncology, R F Mould. Adam Hilger, Bristol 1984; 185–8
- Breast Cancer Trials Committee, Scottish Trials Office. Adjuvant tamoxifen in the management of operable breast cancer: The Scottish trial. Lancet 1987; 1: 171–5
- Rutqvist L E, Cedermark B, Glas U, et al. The Stockholm trial on adjuvant tamoxifen in early breast cancer. Breast Cancer Res Treat 1987; 10: 255–66
- Nolvadex Adjuvant Trial Organisation. Controlled trial of tamoxifen as a single agent in the management of early breast cancer. Br J Cancer 1988; 57: 608–11
- Mouridsen H, Rose C, Overgaard M, et al. Adjuvant treatment of postmenopausal patients with high risk primary breast cancer. Results from the Danish adjuvant trials DBCG 77C and DBCG 82C. Acta Oncol 1988; 27: 699–705
- Vessey M P. Exogenous hormones in the aetiology of cancer in women. J R Soc Med 1984; 77: 542–9
- Powles T J, Hardy J R, Ashley S E, et al. Chemoprevention of breast cancer. Breast Cancer Res Treat 1989; 14: 23–31
- Fisher B, Constantino J, Redmond C, et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node negative breast cancer who have estrogen receptor positive tumors. N Eng J Med 1989; 320: 479–84
- Bruning P F, Bonfrer J MG, Hart A AM, et al. Tamoxifen, serum lipoproteins and cardiovascular risk. Br J Cancer 1988; 58: 497–9